registry – Page 47 – Communicable Diseases Research

Directly Acting Antivirals for COVID-19: Where Do We Stand?

Microbiology

Published on 2020-08-052022-10-31
Journal: Frontiers in Microbiology [Category] COVID-19,

[키워드] Acidic acting Antiviral antivirals approved Case series case sery Characteristics Chinese clinical clinical trial clinical trials conducted coronavirus disease COVID-19 drug Evidence examined Favipiravir genomic identify include influenza infections information inhibitor inhibitors management Novel coronavirus observational studies Other outbreak pandemic pathogenic mechanism polymerase Protease inhibitor randomized controlled study rapid review Registered registry Remdesivir reported required RNA-dependent RNA polymerase SARS-CoV-2 systematic review therapeutic treat umifenovir while Wuhan, China
[DOI] 10.3389/fmicb.2020.01857 PMC 바로가기 [Article Type] Microbiology

Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review

Review article

Published on 2020-08-012022-10-05
Journal: Clinical microbiology and infection : the official [Category] SARS, 신약개발,

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use

Pharmacology

Published on 2020-07-312022-10-31
Journal: Frontiers in Pharmacology [Category] COVID-19,

The safety and effectiveness of rehabilitation exercises on COVID-19 patients A protocol for systematic review and meta-analysis

6600

Published on 2020-07-312022-10-30
Journal: Medicine [Category] COVID-19, SARS,

Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China

Research Article

Published on 2020-07-282022-10-29
Journal: PLoS Medicine [Category] COVID-19, SARS,

[키워드] addition age analyzed antibody Care caused chest X-ray China Chinese clinical clinical feature clinical manifestation complications Computed tomography coronavirus disease cough Course COVID-19 COVID-19 infection death demographic characteristics develop diagnosed diarrhea discharged Evidence Fever Follow-up groups hospital Hospitalized IgG IgM Immunoglobulin Infant Infection intrapartum Laboratory Laboratory test limited sample size majority Maternal Mild symptom multicenter Neonate Neonates nonpregnant outbreak outcome Perinatal Pneumonia positive Pregnancy pregnant pregnant women Premature previous study quarantine radiological feature registry researcher retrospective cohort study Retrospective study SARS-CoV-2 serum Shortness of breath statistical Symptom Symptoms term Transmission vomiting were measured with COVID-19 women Wuhan Wuhan, China X-ray
[DOI] 10.1371/journal.pmed.1003195 PMC 바로가기 [Article Type] Research Article

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

최근 코로나바이러스 질병 2019(COVID-19)에서 회복된 환자의 심혈관 자기 공명 영상의 결과

Observational Study

Published on 2020-07-272022-09-10
Journal: JAMA Cardiology [Category] Fulltext, SARS, 임상, 진단, 치료기술,

[키워드] acute illness acute respiratory syndrome Affect age best Blood cardiovascular cardiovascular system Case report case reports Chain Reaction Characteristics Cohort cohort study Comparisons conditions consequence control group controls coronavirus coronavirus disease Coronavirus disease 2019 correlated Course COVID-19 COVID-19 diagnosis COVID-19 illness COVID-19 infection COVID-19 test demographic demographic characteristics detect detectable determined by Diagnosis Effect Ejection fraction elevated Endomyocardial biopsy evaluate exposure finding Frankfurt gadolinium greater healthy control healthy controls healthy volunteer healthy volunteers hospital Hospitalization hospitalized patient hospitalized patients imaging Importance independent independent of Infection Inflammation IQR left ventricle magnetic resonance imaging male measure median morbidity and mortality Myocardial Myocardial inflammation myocardial injury Native objective participant pathology Patient patients Point prospective observational cohort raised recent recovered registry Relevance required resonance respiratory Result risk risk factor setting severe acute respiratory syndrome Coronavirus severity significant difference significantly Swab test the mean time interval troponin T university upper respiratory tract ventricular ventricular ejection
[DOI] 10.1001/jamacardio.2020.3557 PMC 바로가기 [Article Type] Observational Study

The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19) A protocol for systematic review and meta analysis

3800

Published on 2020-07-242022-10-30
Journal: Medicine [Category] COVID-19, SARS,

HLA-B44 and C01 Prevalence Correlates with Covid19 Spreading across Italy

Communication

Published on 2020-07-232022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19,

[키워드] allele alleles Analysis analyzed Anti-viral Antigen approach case-control studies Clinical management coefficient confounding factors coronavirus correlation COVID-19 Department ecological examined fixed growth HLA HLA allele HLA allele prevalence HLA class I immune response incidence incidence rate increase in infections involved Italian Italy leukocyte limit multiple regression model National outbreak P -value positive Prevalence protection provided registry retrieved risk SARS-COV-2 infection SARS-CoV2 service spread of COVID-19 spreading to define underlie vaccination viral infection susceptibility with COVID-19
[DOI] 10.3390/ijms21155205 PMC 바로가기 [Article Type] Communication

Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry

Review

Published on 2020-07-222022-10-31
Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS,

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-142022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 48 hour addition Administered adverse effect allergy Alpha anticipated assumed baseline blinded to treatment block clinical Clinical outcome Comorbidity COVID-19 data management Day death determine dissemination drug interaction element eligible eligible participant enrolment evaluate evaluated excluded expected group hospital hospitalised hospitalised patient Hydroxychloroquine independent Intensive intensive care Intervention intervention arms invasive investigator investigator-initiated Laboratory Lopinavir management men New no interaction non-invasive ventilation nucleic acid number objective Open-label outcome participant Patient platform Primary outcome proportion Proportion of participant protocol provided QTC prolongation randomisation randomised randomised controlled trial receive receiving recruited reduce Registered registry representing required researcher Respiratory Support risk Ritonavir Sample size SARS-CoV-2 SARS-COV-2 infection secondary outcome sequence significance level Standard of care status stratified study drug Study protocol Tablet total sample size treated Trial two-sided unblinding ventilatory support Virological website women
[DOI] 10.1186/s13063-020-04576-9 PMC 바로가기 [Article Type] Letter